CatalystMarker
← board

PYRGF

distress 5/10 · elevated risk
$0.14+4%today-73% from 52w high
pyrogenesis.com88 employeesMontreal, QCSpecialty Industrial Machinery
Revenue
pre-revenue
Liquidity
$1M
Runway
0.1 yrs
Shares 1y

Price & events

-29.7% over 6M
$0.13$0.31$0.49Jan 26Apr 26Jul 26284k
CatalystRating changeDilutionFinancingdashed = today
+3.8%
1D
-4.9%
1W
-11.2%
1M
-56.5%
3M
-29.7%
6M
-57.4%
1Y
-78.2%
2Y
-96.4%
5Y
-95.5%
All

Overview

Market Cap
$23.43M
Enterprise Value
$23.05M
Volume
3.80K
52 Week Range
$0.13 – $0.49
Total Shares
173.58M
Float Shares
140.46M
% Held by Insiders
27.23%
% Held by Institutions
0.04%
RVOL
0.10x
Beta
1.23

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 1

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 173,580,395 · 0 offerings/1y · 0 PIPEs
  • none
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.